STOCK TITAN

[Form 4] AETHLON MEDICAL INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

FormFactor Inc. (FORM) has filed a Form 144 notice indicating an intended insider sale of up to 4,000 common shares through Morgan Stanley Smith Barney on or about 01 Jul 2025. Based on the filing’s stated aggregate market value of $136,106.80, the planned transaction represents roughly 0.005 % of the company’s 77,076,642 shares outstanding, implying minimal ownership dilution or trading-volume impact.

The seller, identified in the past-sales table as Mike Slessor, acquired the shares as performance stock on 19 Jul 2022. The document notes no gift status or non-cash consideration. Within the preceding three months, the same individual sold 8,000 shares in two tranches (01 May 2025 and 02 Jun 2025) for combined gross proceeds of $246,188.80. Adding the upcoming sale would bring the rolling three-month total to 12,000 shares.

The filing contains the standard representation that the seller is not in possession of undisclosed material adverse information and provides no indication of additional planned transactions beyond the stated amount. Given the modest size relative to market float and the routine nature of a Rule 144 filing, immediate financial impact appears limited; however, continued insider selling can sometimes influence investor sentiment.

FormFactor Inc. (FORM) ha presentato un avviso Form 144 che indica l'intenzione di vendere fino a 4.000 azioni ordinarie tramite Morgan Stanley Smith Barney intorno al 01 luglio 2025. In base al valore di mercato aggregato dichiarato nel documento di 136.106,80 $, l'operazione prevista rappresenta circa lo 0,005 % delle 77.076.642 azioni in circolazione della società, implicando un impatto minimo sulla diluizione della proprietà o sul volume di scambio.

Il venditore, identificato nella tabella delle vendite precedenti come Mike Slessor, ha acquisito le azioni come performance stock il 19 luglio 2022. Il documento non segnala alcuno stato di donazione né compensi non in denaro. Nei tre mesi precedenti, la stessa persona ha venduto 8.000 azioni in due tranche (01 maggio 2025 e 02 giugno 2025) per un ricavo lordo complessivo di 246.188,80 $. Aggiungendo la vendita imminente, il totale su tre mesi salirebbe a 12.000 azioni.

Il documento include la dichiarazione standard che il venditore non è in possesso di informazioni materiali negative non divulgate e non indica ulteriori transazioni programmate oltre a quelle dichiarate. Considerando la dimensione modesta rispetto al flottante di mercato e la natura routinaria di una segnalazione ai sensi della Regola 144, l'impatto finanziario immediato sembra limitato; tuttavia, vendite continue da parte degli insider possono talvolta influenzare il sentimento degli investitori.

FormFactor Inc. (FORM) ha presentado un aviso Formulario 144 indicando la intención de vender hasta 4,000 acciones comunes a través de Morgan Stanley Smith Barney aproximadamente el 01 de julio de 2025. Según el valor de mercado agregado declarado en la presentación de $136,106.80, la transacción planeada representa aproximadamente el 0.005 % de las 77,076,642 acciones en circulación de la compañía, lo que implica una dilución mínima de la propiedad o impacto en el volumen de negociación.

El vendedor, identificado en la tabla de ventas anteriores como Mike Slessor, adquirió las acciones como acciones de desempeño el 19 de julio de 2022. El documento no indica estado de donación ni contraprestación no monetaria. En los tres meses previos, la misma persona vendió 8,000 acciones en dos tramos (01 de mayo de 2025 y 02 de junio de 2025) por un total bruto combinado de $246,188.80. Sumando la venta próxima, el total en tres meses sería de 12,000 acciones.

La presentación contiene la declaración estándar de que el vendedor no posee información material adversa no divulgada y no indica transacciones adicionales planeadas más allá de la cantidad declarada. Dado el tamaño modesto en relación con el flotante del mercado y la naturaleza rutinaria de una presentación bajo la Regla 144, el impacto financiero inmediato parece limitado; sin embargo, la venta continua por parte de los internos puede a veces influir en el sentimiento de los inversores.

FormFactor Inc. (FORM)는 Form 144 공시를 제출하여 Morgan Stanley Smith Barney를 통해 2025년 7월 1일경 최대 4,000주 보통주를 내부자 매도할 계획임을 알렸습니다. 공시에 명시된 총 시장 가액 $136,106.80을 기준으로 이번 거래는 회사의 77,076,642주 발행 주식 중 약 0.005 %에 해당하며, 소유권 희석이나 거래량에 미치는 영향은 미미할 것으로 보입니다.

판매자는 과거 매도 내역 표에 Mike Slessor로 기록되어 있으며, 2022년 7월 19일 성과 주식(performance stock)으로 주식을 취득했습니다. 문서에는 증여 상태나 현금 외 대가가 없음을 명시하고 있습니다. 최근 3개월 동안 동일인이 두 차례(2025년 5월 1일 및 6월 2일)에 걸쳐 8,000주를 매도하여 총 매출액 $246,188.80을 기록했습니다. 이번 매도를 포함하면 3개월 누적 매도량은 12,000주가 됩니다.

공시는 판매자가 미공개 중대한 악재 정보를 보유하지 않았음을 표준적으로 진술하며, 명시된 금액 외 추가 거래 계획은 없음을 나타냅니다. 시장 유통 주식 대비 규모가 작고 규칙 144에 따른 일반적인 신고임을 감안할 때 즉각적인 재무 영향은 제한적일 것으로 보이나, 내부자 매도가 지속되면 투자자 심리에 영향을 줄 수 있습니다.

FormFactor Inc. (FORM) a déposé un avis Formulaire 144 indiquant son intention de vendre jusqu'à 4 000 actions ordinaires via Morgan Stanley Smith Barney aux alentours du 1er juillet 2025. D'après la valeur marchande agrégée indiquée dans le dépôt, soit 136 106,80 $, la transaction prévue représente environ 0,005 % des 77 076 642 actions en circulation de la société, ce qui implique une dilution minimale de la propriété ou un impact négligeable sur le volume des échanges.

Le vendeur, identifié dans le tableau des ventes précédentes comme Mike Slessor, a acquis les actions en tant que performance stock le 19 juillet 2022. Le document ne mentionne aucun statut de don ni contrepartie non monétaire. Au cours des trois mois précédents, cette même personne a vendu 8 000 actions en deux tranches (1er mai 2025 et 2 juin 2025) pour un produit brut total combiné de 246 188,80 $. En ajoutant la vente à venir, le total sur trois mois atteindrait 12 000 actions.

Le dépôt contient la déclaration standard précisant que le vendeur ne détient pas d'informations matérielles défavorables non divulguées et ne fait état d'aucune transaction supplémentaire prévue au-delà du montant indiqué. Étant donné la taille modeste par rapport au flottant et la nature routinière d'un dépôt selon la règle 144, l'impact financier immédiat semble limité ; cependant, des ventes continues par des initiés peuvent parfois influencer le sentiment des investisseurs.

FormFactor Inc. (FORM) hat eine Form 144-Meldung eingereicht, die einen geplanten Insider-Verkauf von bis zu 4.000 Stammaktien über Morgan Stanley Smith Barney um den 01. Juli 2025 herum anzeigt. Basierend auf dem im Formular angegebenen aggregierten Marktwert von 136.106,80 $ entspricht die geplante Transaktion etwa 0,005 % der 77.076.642 ausstehenden Aktien des Unternehmens, was auf eine minimale Verwässerung der Eigentumsanteile oder einen geringen Einfluss auf das Handelsvolumen hindeutet.

Der Verkäufer, in der Tabelle der vergangenen Verkäufe als Mike Slessor identifiziert, erwarb die Aktien als Performance-Aktien am 19. Juli 2022. Das Dokument vermerkt keinen Schenkungsstatus oder nicht-monetäre Gegenleistungen. Innerhalb der letzten drei Monate verkaufte dieselbe Person 8.000 Aktien in zwei Tranchen (01. Mai 2025 und 02. Juni 2025) mit einem Bruttogesamterlös von 246.188,80 $. Mit dem geplanten Verkauf würde sich die Gesamtsumme innerhalb von drei Monaten auf 12.000 Aktien erhöhen.

Die Meldung enthält die übliche Erklärung, dass der Verkäufer keine nicht offengelegten wesentlichen negativen Informationen besitzt, und gibt keinen Hinweis auf weitere geplante Transaktionen über die angegebene Menge hinaus. Angesichts der bescheidenen Größe im Verhältnis zum Streubesitz und der routinemäßigen Natur einer Regel-144-Meldung erscheint die unmittelbare finanzielle Auswirkung begrenzt; dennoch kann fortgesetzter Insider-Verkauf manchmal die Anlegerstimmung beeinflussen.

Positive
  • Regulatory compliance: Timely Form 144 filing demonstrates transparency and adherence to SEC insider-sale rules.
Negative
  • Continued insider selling: Aggregate 12,000 shares sold or planned within three months could be perceived as waning insider confidence, despite small relative size.

Insights

TL;DR: Small insider sale (0.005 % float) is routine; sentiment risk minor, fundamental impact negligible.

The filing covers 4,000 shares worth about $136k, following two earlier 4,000-share tranches. Even aggregated, 12,000 shares equal only ~0.016 % of outstanding stock, so supply overhang is immaterial. Because the shares derive from performance awards, the sale may simply reflect personal diversification rather than adverse views on FormFactor’s outlook. No pricing details beyond market value are disclosed, and nothing in the notice suggests undisclosed operational issues. From a valuation standpoint, therefore, I see neutral financial impact; the primary takeaway is a potential marginal sentiment headwind if investors focus on the insider activity.

TL;DR: Filing signals compliance and transparency; repeated sales could draw light governance scrutiny.

Rule 144 notices are expected when insiders dispose of restricted stock. The prompt disclosure underscores adherence to SEC requirements, which is governance-positive. Nonetheless, three sales within three months may trigger investor questions about executive alignment, especially absent offsetting insider purchases. The percentage sold is immaterial to control, so no governance red flags arise. Overall, the event is non-impactful but worth monitoring if sales accelerate.

FormFactor Inc. (FORM) ha presentato un avviso Form 144 che indica l'intenzione di vendere fino a 4.000 azioni ordinarie tramite Morgan Stanley Smith Barney intorno al 01 luglio 2025. In base al valore di mercato aggregato dichiarato nel documento di 136.106,80 $, l'operazione prevista rappresenta circa lo 0,005 % delle 77.076.642 azioni in circolazione della società, implicando un impatto minimo sulla diluizione della proprietà o sul volume di scambio.

Il venditore, identificato nella tabella delle vendite precedenti come Mike Slessor, ha acquisito le azioni come performance stock il 19 luglio 2022. Il documento non segnala alcuno stato di donazione né compensi non in denaro. Nei tre mesi precedenti, la stessa persona ha venduto 8.000 azioni in due tranche (01 maggio 2025 e 02 giugno 2025) per un ricavo lordo complessivo di 246.188,80 $. Aggiungendo la vendita imminente, il totale su tre mesi salirebbe a 12.000 azioni.

Il documento include la dichiarazione standard che il venditore non è in possesso di informazioni materiali negative non divulgate e non indica ulteriori transazioni programmate oltre a quelle dichiarate. Considerando la dimensione modesta rispetto al flottante di mercato e la natura routinaria di una segnalazione ai sensi della Regola 144, l'impatto finanziario immediato sembra limitato; tuttavia, vendite continue da parte degli insider possono talvolta influenzare il sentimento degli investitori.

FormFactor Inc. (FORM) ha presentado un aviso Formulario 144 indicando la intención de vender hasta 4,000 acciones comunes a través de Morgan Stanley Smith Barney aproximadamente el 01 de julio de 2025. Según el valor de mercado agregado declarado en la presentación de $136,106.80, la transacción planeada representa aproximadamente el 0.005 % de las 77,076,642 acciones en circulación de la compañía, lo que implica una dilución mínima de la propiedad o impacto en el volumen de negociación.

El vendedor, identificado en la tabla de ventas anteriores como Mike Slessor, adquirió las acciones como acciones de desempeño el 19 de julio de 2022. El documento no indica estado de donación ni contraprestación no monetaria. En los tres meses previos, la misma persona vendió 8,000 acciones en dos tramos (01 de mayo de 2025 y 02 de junio de 2025) por un total bruto combinado de $246,188.80. Sumando la venta próxima, el total en tres meses sería de 12,000 acciones.

La presentación contiene la declaración estándar de que el vendedor no posee información material adversa no divulgada y no indica transacciones adicionales planeadas más allá de la cantidad declarada. Dado el tamaño modesto en relación con el flotante del mercado y la naturaleza rutinaria de una presentación bajo la Regla 144, el impacto financiero inmediato parece limitado; sin embargo, la venta continua por parte de los internos puede a veces influir en el sentimiento de los inversores.

FormFactor Inc. (FORM)는 Form 144 공시를 제출하여 Morgan Stanley Smith Barney를 통해 2025년 7월 1일경 최대 4,000주 보통주를 내부자 매도할 계획임을 알렸습니다. 공시에 명시된 총 시장 가액 $136,106.80을 기준으로 이번 거래는 회사의 77,076,642주 발행 주식 중 약 0.005 %에 해당하며, 소유권 희석이나 거래량에 미치는 영향은 미미할 것으로 보입니다.

판매자는 과거 매도 내역 표에 Mike Slessor로 기록되어 있으며, 2022년 7월 19일 성과 주식(performance stock)으로 주식을 취득했습니다. 문서에는 증여 상태나 현금 외 대가가 없음을 명시하고 있습니다. 최근 3개월 동안 동일인이 두 차례(2025년 5월 1일 및 6월 2일)에 걸쳐 8,000주를 매도하여 총 매출액 $246,188.80을 기록했습니다. 이번 매도를 포함하면 3개월 누적 매도량은 12,000주가 됩니다.

공시는 판매자가 미공개 중대한 악재 정보를 보유하지 않았음을 표준적으로 진술하며, 명시된 금액 외 추가 거래 계획은 없음을 나타냅니다. 시장 유통 주식 대비 규모가 작고 규칙 144에 따른 일반적인 신고임을 감안할 때 즉각적인 재무 영향은 제한적일 것으로 보이나, 내부자 매도가 지속되면 투자자 심리에 영향을 줄 수 있습니다.

FormFactor Inc. (FORM) a déposé un avis Formulaire 144 indiquant son intention de vendre jusqu'à 4 000 actions ordinaires via Morgan Stanley Smith Barney aux alentours du 1er juillet 2025. D'après la valeur marchande agrégée indiquée dans le dépôt, soit 136 106,80 $, la transaction prévue représente environ 0,005 % des 77 076 642 actions en circulation de la société, ce qui implique une dilution minimale de la propriété ou un impact négligeable sur le volume des échanges.

Le vendeur, identifié dans le tableau des ventes précédentes comme Mike Slessor, a acquis les actions en tant que performance stock le 19 juillet 2022. Le document ne mentionne aucun statut de don ni contrepartie non monétaire. Au cours des trois mois précédents, cette même personne a vendu 8 000 actions en deux tranches (1er mai 2025 et 2 juin 2025) pour un produit brut total combiné de 246 188,80 $. En ajoutant la vente à venir, le total sur trois mois atteindrait 12 000 actions.

Le dépôt contient la déclaration standard précisant que le vendeur ne détient pas d'informations matérielles défavorables non divulguées et ne fait état d'aucune transaction supplémentaire prévue au-delà du montant indiqué. Étant donné la taille modeste par rapport au flottant et la nature routinière d'un dépôt selon la règle 144, l'impact financier immédiat semble limité ; cependant, des ventes continues par des initiés peuvent parfois influencer le sentiment des investisseurs.

FormFactor Inc. (FORM) hat eine Form 144-Meldung eingereicht, die einen geplanten Insider-Verkauf von bis zu 4.000 Stammaktien über Morgan Stanley Smith Barney um den 01. Juli 2025 herum anzeigt. Basierend auf dem im Formular angegebenen aggregierten Marktwert von 136.106,80 $ entspricht die geplante Transaktion etwa 0,005 % der 77.076.642 ausstehenden Aktien des Unternehmens, was auf eine minimale Verwässerung der Eigentumsanteile oder einen geringen Einfluss auf das Handelsvolumen hindeutet.

Der Verkäufer, in der Tabelle der vergangenen Verkäufe als Mike Slessor identifiziert, erwarb die Aktien als Performance-Aktien am 19. Juli 2022. Das Dokument vermerkt keinen Schenkungsstatus oder nicht-monetäre Gegenleistungen. Innerhalb der letzten drei Monate verkaufte dieselbe Person 8.000 Aktien in zwei Tranchen (01. Mai 2025 und 02. Juni 2025) mit einem Bruttogesamterlös von 246.188,80 $. Mit dem geplanten Verkauf würde sich die Gesamtsumme innerhalb von drei Monaten auf 12.000 Aktien erhöhen.

Die Meldung enthält die übliche Erklärung, dass der Verkäufer keine nicht offengelegten wesentlichen negativen Informationen besitzt, und gibt keinen Hinweis auf weitere geplante Transaktionen über die angegebene Menge hinaus. Angesichts der bescheidenen Größe im Verhältnis zum Streubesitz und der routinemäßigen Natur einer Regel-144-Meldung erscheint die unmittelbare finanzielle Auswirkung begrenzt; dennoch kann fortgesetzter Insider-Verkauf manchmal die Anlegerstimmung beeinflussen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gikakis Nicolas

(Last) (First) (Middle)
11555 SORRENTO VALLEY ROAD, SUITE 203

(Street)
SAN DIEGO CA 92121

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AETHLON MEDICAL INC [ AEMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/30/2025 F 1,786(1) D $1.2 20,004 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The Reporting Person forfeited 1,786 shares of common stock upon conversion of an aggregate 4,465 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025.
/s/ Nicolas Gikakis, by: James B. Frakes, Attorney-in-fact 07/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many FormFactor (FORM) shares are covered by the new Form 144 filing?

The notice covers 4,000 common shares.

What is the approximate market value of the shares to be sold?

The aggregate market value stated is $136,106.80.

When is the planned sale date for the Form 144 shares?

The filer lists an approximate sale date of 01 July 2025.

What percentage of FormFactor’s outstanding shares does 4,000 shares represent?

Roughly 0.005 % of the 77,076,642 shares outstanding.

What insider sales occurred in the prior three months?

The same seller disposed of 8,000 shares in May and June 2025 for total proceeds of $246,188.80.

Who is the broker executing the proposed transaction?

The broker is Morgan Stanley Smith Barney LLC, Executive Financial Services, New York.
Aethlon Medical

NASDAQ:AEMD

AEMD Rankings

AEMD Latest News

AEMD Latest SEC Filings

AEMD Stock Data

5.02M
1.99M
0.33%
7.78%
3.32%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SAN DIEGO